I’m in Biomarin since 2006, I made the Italian start up but also contributed to establish the European subsidiary . I’m currently oversighting the following countries : Portugal, UK, IRL, BeNelux, Nordics, Austria, Switzerland, Greece, East Europe, Russia, CSI, Israel, Australia and New Zealand. I’m part of the Executive Team of Biomarin Europe. Highly motivated, visionary and committed to innovation, actually my professional role comes together with my commitment at an associative level to Assobiotec for the promotion and development of the biotechnology industries, in which I contributed to fund the Working Group of Rare Disease and Orphan Drugs.In my career I dealt with Pricing & Reimbursement, Early Access Programs, MKTG & Sales, Regulatory, Interaction with KOLs and Patient Groups have been part of daily work.Proven ability to lead, inspire and develop teams to consistently drive growth and achieve P&L objectives, combined with strong experience in Rare Disease and Orphan Drugs as well as start up companies or projects .Proven ability to network, building valuable relationships and trust with key stakeholders. Entrepreneurial mindset, strongly customer-focused and passionate.Area of expertise: -Orphan Medicinal Products/Rare Diseases-Start up-Market Acces, Name Patient programs-Forecasting & Finance-New products planning scenario-Deployment and planning resources